Dennis L. Winger, Director at NEKTAR THERAPEUTICS (NKTR), bought 5,000 shares at $9.18 ($46K) on 2012-09-14, disclosed to the SEC on 2012-09-18.
Open-market purchase of $46k NKTR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| PCRX | BUY | 2014-12-08 | $250K | — | Filing → |
| ARAY | BUY | 2013-03-05 | $86K | — | Filing → |
| VRTX | BUY | 2010-02-18 | $251K | — | Filing → |